CIK 0001787400
- Non-accelerated filer
- Smaller reporting company
Nkarta, Inc.
Sign in to watch- Ticker
- NKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474515206
- Phone
- +1 925-407-1049
- Business address
- 1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale Chief Technical Officer sold 8,367 shares at $12.51 ($104,671)
- 4 Open-market sale Chief Scientific Officer sold 4,143 shares at $12.00 ($49,716)
- 4 Open-market sale Chief Medical Officer sold 3,552 shares at $8.74 ($31,044)
- 4 Open-market sale Chief Scientific Officer sold 4,560 shares at $8.74 ($39,854)
- 4 Open-market sale Chief Technical Officer sold 2,512 shares at $8.74 ($21,955)
- 4 Open-market sale Chief Executive Officer sold 9,697 shares at $8.74 ($84,752)
- 4 Open-market sale Chief Legal Officer sold 4,554 shares at $8.74 ($39,802)
- 4 Grant or award Chief Medical Officer acquired 56,000 shares (grant or award)
- 4 Grant or award Chief Technical Officer acquired 56,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 56,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 85,000 shares (grant or award)
- 4 Grant or award Levin Alyssa acquired 56,000 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 56,000 shares (grant or award)
- 4 Open-market sale Chief Medical Officer sold 1,331 shares at $1.83 ($2,436)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 439 shares at $4.85 ($2,129)
- 4 Open-market sale Chief Technical Officer sold 221 shares at $4.85 ($1,072)
- 4 Open-market sale Chief Legal Officer sold 701 shares at $4.85 ($3,400)
Page 4 of 11 · 218 filings